drugset / Trial / NCT02985632
A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
An oral dose of BMS-986141 administered in Hepatic Impairment and Healthy Participants to evaluate pharmacokinetics in this patient population.
Timeline
- Start
- 2017-01-11
- Primary completion
- 2017-05-18
- Completion
- 2017-07-07
Outcome
Outcome not reported
Stopped (Business): “Business objectives have changed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986141 | Small molecule | — | Oral |
Indications
No indication recorded.